Skip to main content

High Rate of Comorbid Mental Health Disorders Seen in Schizophrenia

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 8, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 8, 2024 -- Adults with schizophrenia spectrum disorders have high rates of comorbid mental health and substance use disorders, according to a study published online Sept. 23 in Psychiatric Services.

Natalie Bareis, Ph.D., from the Columbia University Irving Medical Center in New York City, and colleagues used data from the U.S. Mental and Substance Use Disorders Prevalence Study to examine treatment and clinical characteristics of U.S. adults with schizophrenia spectrum disorders. Sociodemographic characteristics and comorbid behavioral health conditions were compared for 4,764 adults with or without schizophrenia disorders.

The most common comorbid conditions among 114 adults with schizophrenia spectrum disorders were major depressive episode (52 percent) and alcohol use, cannabis use, and posttraumatic stress disorders (23, 20, and 17 percent, respectively). The researchers found that among people with versus without schizophrenia spectrum disorders, Global Assessment of Functioning scores were lower (mean, 44.8 ± 2.0 versus 77.2 ± 0.5), indicating worse functioning. Seventy-one percent of adults with schizophrenia spectrum disorders received at least some mental health treatment in the past year, and 26 percent received minimally adequate treatment.

"These findings further suggest that existing treatment and social welfare approaches are not meeting the needs of many people with schizophrenia spectrum disorders," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted October 2024

Read this next

Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise

WEDNESDAY, April 30, 2025 -- The percentage of publicly insured children receiving any mental health or neurodevelopmental disorder diagnosis significantly increased between 2010...

2019 to 2023 Saw Increase in Prevalence of Psilocybin Use in the United States

TUESDAY, April 29, 2025 -- The prevalence of lifetime and past-year use of psilocybin increased from 2019 to 2023 among all age groups in the United States, according to a study...

Risky Health Behaviors Tied to Poorer Mental Well-Being, General Health in Midlife

MONDAY, April 28, 2025 -- Risky health behaviors, both current and cumulatively over time, are associated with poorer mental well-being and self-reported health, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.